Phase 2a Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors
Condition(s):Small Cell Lung Cancer (SCLC); Neuroendocrine TumorsLast Updated:April 17, 2017Terminated
Hide Studies Not Open or Pending
Condition(s):Small Cell Lung Cancer (SCLC); Neuroendocrine TumorsLast Updated:April 17, 2017Terminated
Condition(s):DS (Durie/Salmon) Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma; Refractory Plasma Cell MyelomaLast Updated:March 28, 2023Terminated
Condition(s):Pharmacokinetics of Mirabegron; Healthy SubjectsLast Updated:April 10, 2014Completed
Condition(s):Chronic PainLast Updated:November 22, 2023Recruiting
Condition(s):Sleep Apnea, ObstructiveLast Updated:March 30, 2017Completed
Condition(s):Irritable Bowel SyndromeLast Updated:August 31, 2022Completed
Condition(s):Rett SyndromeLast Updated:July 26, 2018Completed
Condition(s):Sleep Apnea, ObstructiveLast Updated:March 30, 2017Completed
Condition(s):Infantile Neuroaxonal DystrophyLast Updated:October 14, 2020Terminated
Condition(s):Schizophrenia; Alcoholism; Dual DiagnosisLast Updated:March 23, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.